HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS		QUICK SEARCH:   [advanced] Author: Keyword(s): Year:  Vol:  Page:

This Article Full Text Full Text (PDF) Submit an electronic Letter to the Editor about this paper Alert me when this article is cited Alert me when eLetters are posted Alert me if a correction is posted Services Email this article to a friend Similar articles in this journal Similar articles in ISI Web of Science Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Citing Articles Citing Articles via HighWire Citing Articles via ISI Web of Science (11) Citing Articles via Google Scholar Google Scholar Articles by Picarelli, A. Articles by Anania, M. C. Search for Related Content PubMed PubMed Citation Articles by Picarelli, A. Articles by Anania, M. C. Related Collections Clinical Immunology

Forty-Eight Hours of Biopsy Culture Improve the Sensitivity of the in Vitro Gliadin Challenge in the Diagnosis of Celiac Disease

Departments of
¹ Clinical Sciences and
² Experimental Medicine, University "La Sapienza", 155-00161 Rome, Italy

^aaddress correspondence to this author at: Department of Clinical Sciences, Policlinico "Umberto I", University of Rome "La Sapienza", Viale del Policlinico, 155-00161 Rome, Italy; fax 39-06-49970524, e-mail a.picarelli@flashnet.it

Celiac disease (CD) is a long-life intolerance to gliadin in genetically susceptible individuals (1)(2)(3)(4)(5)(6). Despite contrary views (7), diagnosis is still based on the histologic findings of intestinal mucosal atrophy with crypt hyperplasia in individuals on a gluten-containing diet and a return to normal after a gluten-free diet (GFD). The presence of circulating anti-endomysial antibodies (EMAs) and their disappearance after GFD confirm the diagnosis (8)(9)(10). It has recently been shown that EMAs are produced by intestinal mucosa of CD patients. EMAs disappear in treated CD patients but are newly produced after in vitro exposure of intestinal biopsy samples to gliadin (11).

Culture of intestinal mucosa from treated CD patients in the presence of a peptic-tryptic (PT) digest of gliadin for 24 h frequently fails to produce detectable EMAs, but it has high specificity as well as high sensitivity in overt CD (12). Our aim was to increase the sensitivity of the in vitro culture by prolonging the duration to 48 h. We also tested a new culture method in batch to ease testing.

We enrolled 11 untreated, EMA-positive CD patients (5 males and 6 females; mean age, 24.7 years; age range, 17–42 years) and 29 treated CD patients (11 males and 18 females; mean age, 32.0 years; age range, 11–70 years) after at least 12 months of GFD (median length of GFD, 730 days; range, 342–4015 days) and two monthly, consecutive serum EMA tests that were negative. As disease-controls we studied 67 patients (20 males and 47 females, mean age, 35.3 years; age range, 20–50 years) with gastrointestinal diseases other than CD (42 with gastroesophageal reflux disease, 8 with ulcer disease, 3 with ulcerative colitis, 3 . . . [Full Text of this Article]

Classic method (4).

Batch method.

Acknowledgments

References

The following articles in journals at HighWire Press have cited this article:

				M Esteve, M Rosinach, F Fernandez-Banares, C Farre, A Salas, M Alsina, P Vilar, A Abad-Lacruz, M Forne, M Marine, et al. Spectrum of gluten-sensitive enteropathy in first-degree relatives of patients with coeliac disease: clinical relevance of lymphocytic enteritis Gut, December 1, 2006; 55(12): 1739 - 1745. [Abstract] [Full Text] [PDF]